CLINICAL FOLLOW-UP OF A PATIENT WITH OBESITY AND SUBCLINICAL HYPOTHYROIDISM DURING TREATMENT WITH SIBUTRAMINE AND LEVOTHYROXINE SODIUM
Among comorbidities of obesity, hypothyroidism is the most common endocrinopathy. The pathogenesis of both diseases is based on serotonin deficiency. The article tells about a clinical case of a patient with obesity and subclinical hypothyroidism; a comprehensive examination allowed to choose the ef...
Ausführliche Beschreibung
Gespeichert in:
| Autor*in: |
E. A. Troshina [verfasserIn] M. O. Galieva [verfasserIn] M. S. Mikhina [verfasserIn] N. V. Mazurina [verfasserIn] |
|---|
| Format: |
E-Artikel |
|---|---|
| Sprache: |
Russisch |
| Erschienen: |
2017 |
|---|
| Schlagwörter: |
|---|
| Übergeordnetes Werk: |
In: Медицинский совет - Remedium Group LLC, 2019, (2017), 3, Seite 80-83 |
|---|---|
| Übergeordnetes Werk: |
year:2017 ; number:3 ; pages:80-83 |
| Links: |
Link aufrufen |
|---|
| DOI / URN: |
10.21518/2079-701X-2017-3-80-83 |
|---|
| Katalog-ID: |
DOAJ033461155 |
|---|
| LEADER | 01000caa a22002652 4500 | ||
|---|---|---|---|
| 001 | DOAJ033461155 | ||
| 003 | DE-627 | ||
| 005 | 20230505014249.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 230226s2017 xx |||||o 00| ||rus c | ||
| 024 | 7 | |a 10.21518/2079-701X-2017-3-80-83 |2 doi | |
| 035 | |a (DE-627)DOAJ033461155 | ||
| 035 | |a (DE-599)DOAJ9e90ccae619242999620e890c01aa97f | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a rus | ||
| 100 | 0 | |a E. A. Troshina |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a CLINICAL FOLLOW-UP OF A PATIENT WITH OBESITY AND SUBCLINICAL HYPOTHYROIDISM DURING TREATMENT WITH SIBUTRAMINE AND LEVOTHYROXINE SODIUM |
| 264 | 1 | |c 2017 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a Computermedien |b c |2 rdamedia | ||
| 338 | |a Online-Ressource |b cr |2 rdacarrier | ||
| 520 | |a Among comorbidities of obesity, hypothyroidism is the most common endocrinopathy. The pathogenesis of both diseases is based on serotonin deficiency. The article tells about a clinical case of a patient with obesity and subclinical hypothyroidism; a comprehensive examination allowed to choose the efficient and safe pathogenetic therapy. | ||
| 650 | 4 | |a obesity | |
| 650 | 4 | |a hypothyroidism | |
| 650 | 4 | |a sibutramine | |
| 650 | 4 | |a mass spectrometry | |
| 653 | 0 | |a Medicine | |
| 653 | 0 | |a R | |
| 700 | 0 | |a M. O. Galieva |e verfasserin |4 aut | |
| 700 | 0 | |a M. S. Mikhina |e verfasserin |4 aut | |
| 700 | 0 | |a N. V. Mazurina |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i In |t Медицинский совет |d Remedium Group LLC, 2019 |g (2017), 3, Seite 80-83 |w (DE-627)1760607460 |x 26585790 |7 nnns |
| 773 | 1 | 8 | |g year:2017 |g number:3 |g pages:80-83 |
| 856 | 4 | 0 | |u https://doi.org/10.21518/2079-701X-2017-3-80-83 |z kostenfrei |
| 856 | 4 | 0 | |u https://doaj.org/article/9e90ccae619242999620e890c01aa97f |z kostenfrei |
| 856 | 4 | 0 | |u https://www.med-sovet.pro/jour/article/view/1755 |z kostenfrei |
| 856 | 4 | 2 | |u https://doaj.org/toc/2079-701X |y Journal toc |z kostenfrei |
| 856 | 4 | 2 | |u https://doaj.org/toc/2658-5790 |y Journal toc |z kostenfrei |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a SYSFLAG_A | ||
| 912 | |a GBV_DOAJ | ||
| 951 | |a AR | ||
| 952 | |j 2017 |e 3 |h 80-83 | ||
| author_variant |
e a t eat m o g mog m s m msm n v m nvm |
|---|---|
| matchkey_str |
article:26585790:2017----::lnclolwpfptetihbstaduciiahptyodsdrntetetihi |
| hierarchy_sort_str |
2017 |
| publishDate |
2017 |
| allfields |
10.21518/2079-701X-2017-3-80-83 doi (DE-627)DOAJ033461155 (DE-599)DOAJ9e90ccae619242999620e890c01aa97f DE-627 ger DE-627 rakwb rus E. A. Troshina verfasserin aut CLINICAL FOLLOW-UP OF A PATIENT WITH OBESITY AND SUBCLINICAL HYPOTHYROIDISM DURING TREATMENT WITH SIBUTRAMINE AND LEVOTHYROXINE SODIUM 2017 Text txt rdacontent Computermedien c rdamedia Online-Ressource cr rdacarrier Among comorbidities of obesity, hypothyroidism is the most common endocrinopathy. The pathogenesis of both diseases is based on serotonin deficiency. The article tells about a clinical case of a patient with obesity and subclinical hypothyroidism; a comprehensive examination allowed to choose the efficient and safe pathogenetic therapy. obesity hypothyroidism sibutramine mass spectrometry Medicine R M. O. Galieva verfasserin aut M. S. Mikhina verfasserin aut N. V. Mazurina verfasserin aut In Медицинский совет Remedium Group LLC, 2019 (2017), 3, Seite 80-83 (DE-627)1760607460 26585790 nnns year:2017 number:3 pages:80-83 https://doi.org/10.21518/2079-701X-2017-3-80-83 kostenfrei https://doaj.org/article/9e90ccae619242999620e890c01aa97f kostenfrei https://www.med-sovet.pro/jour/article/view/1755 kostenfrei https://doaj.org/toc/2079-701X Journal toc kostenfrei https://doaj.org/toc/2658-5790 Journal toc kostenfrei GBV_USEFLAG_A SYSFLAG_A GBV_DOAJ AR 2017 3 80-83 |
| spelling |
10.21518/2079-701X-2017-3-80-83 doi (DE-627)DOAJ033461155 (DE-599)DOAJ9e90ccae619242999620e890c01aa97f DE-627 ger DE-627 rakwb rus E. A. Troshina verfasserin aut CLINICAL FOLLOW-UP OF A PATIENT WITH OBESITY AND SUBCLINICAL HYPOTHYROIDISM DURING TREATMENT WITH SIBUTRAMINE AND LEVOTHYROXINE SODIUM 2017 Text txt rdacontent Computermedien c rdamedia Online-Ressource cr rdacarrier Among comorbidities of obesity, hypothyroidism is the most common endocrinopathy. The pathogenesis of both diseases is based on serotonin deficiency. The article tells about a clinical case of a patient with obesity and subclinical hypothyroidism; a comprehensive examination allowed to choose the efficient and safe pathogenetic therapy. obesity hypothyroidism sibutramine mass spectrometry Medicine R M. O. Galieva verfasserin aut M. S. Mikhina verfasserin aut N. V. Mazurina verfasserin aut In Медицинский совет Remedium Group LLC, 2019 (2017), 3, Seite 80-83 (DE-627)1760607460 26585790 nnns year:2017 number:3 pages:80-83 https://doi.org/10.21518/2079-701X-2017-3-80-83 kostenfrei https://doaj.org/article/9e90ccae619242999620e890c01aa97f kostenfrei https://www.med-sovet.pro/jour/article/view/1755 kostenfrei https://doaj.org/toc/2079-701X Journal toc kostenfrei https://doaj.org/toc/2658-5790 Journal toc kostenfrei GBV_USEFLAG_A SYSFLAG_A GBV_DOAJ AR 2017 3 80-83 |
| allfields_unstemmed |
10.21518/2079-701X-2017-3-80-83 doi (DE-627)DOAJ033461155 (DE-599)DOAJ9e90ccae619242999620e890c01aa97f DE-627 ger DE-627 rakwb rus E. A. Troshina verfasserin aut CLINICAL FOLLOW-UP OF A PATIENT WITH OBESITY AND SUBCLINICAL HYPOTHYROIDISM DURING TREATMENT WITH SIBUTRAMINE AND LEVOTHYROXINE SODIUM 2017 Text txt rdacontent Computermedien c rdamedia Online-Ressource cr rdacarrier Among comorbidities of obesity, hypothyroidism is the most common endocrinopathy. The pathogenesis of both diseases is based on serotonin deficiency. The article tells about a clinical case of a patient with obesity and subclinical hypothyroidism; a comprehensive examination allowed to choose the efficient and safe pathogenetic therapy. obesity hypothyroidism sibutramine mass spectrometry Medicine R M. O. Galieva verfasserin aut M. S. Mikhina verfasserin aut N. V. Mazurina verfasserin aut In Медицинский совет Remedium Group LLC, 2019 (2017), 3, Seite 80-83 (DE-627)1760607460 26585790 nnns year:2017 number:3 pages:80-83 https://doi.org/10.21518/2079-701X-2017-3-80-83 kostenfrei https://doaj.org/article/9e90ccae619242999620e890c01aa97f kostenfrei https://www.med-sovet.pro/jour/article/view/1755 kostenfrei https://doaj.org/toc/2079-701X Journal toc kostenfrei https://doaj.org/toc/2658-5790 Journal toc kostenfrei GBV_USEFLAG_A SYSFLAG_A GBV_DOAJ AR 2017 3 80-83 |
| allfieldsGer |
10.21518/2079-701X-2017-3-80-83 doi (DE-627)DOAJ033461155 (DE-599)DOAJ9e90ccae619242999620e890c01aa97f DE-627 ger DE-627 rakwb rus E. A. Troshina verfasserin aut CLINICAL FOLLOW-UP OF A PATIENT WITH OBESITY AND SUBCLINICAL HYPOTHYROIDISM DURING TREATMENT WITH SIBUTRAMINE AND LEVOTHYROXINE SODIUM 2017 Text txt rdacontent Computermedien c rdamedia Online-Ressource cr rdacarrier Among comorbidities of obesity, hypothyroidism is the most common endocrinopathy. The pathogenesis of both diseases is based on serotonin deficiency. The article tells about a clinical case of a patient with obesity and subclinical hypothyroidism; a comprehensive examination allowed to choose the efficient and safe pathogenetic therapy. obesity hypothyroidism sibutramine mass spectrometry Medicine R M. O. Galieva verfasserin aut M. S. Mikhina verfasserin aut N. V. Mazurina verfasserin aut In Медицинский совет Remedium Group LLC, 2019 (2017), 3, Seite 80-83 (DE-627)1760607460 26585790 nnns year:2017 number:3 pages:80-83 https://doi.org/10.21518/2079-701X-2017-3-80-83 kostenfrei https://doaj.org/article/9e90ccae619242999620e890c01aa97f kostenfrei https://www.med-sovet.pro/jour/article/view/1755 kostenfrei https://doaj.org/toc/2079-701X Journal toc kostenfrei https://doaj.org/toc/2658-5790 Journal toc kostenfrei GBV_USEFLAG_A SYSFLAG_A GBV_DOAJ AR 2017 3 80-83 |
| allfieldsSound |
10.21518/2079-701X-2017-3-80-83 doi (DE-627)DOAJ033461155 (DE-599)DOAJ9e90ccae619242999620e890c01aa97f DE-627 ger DE-627 rakwb rus E. A. Troshina verfasserin aut CLINICAL FOLLOW-UP OF A PATIENT WITH OBESITY AND SUBCLINICAL HYPOTHYROIDISM DURING TREATMENT WITH SIBUTRAMINE AND LEVOTHYROXINE SODIUM 2017 Text txt rdacontent Computermedien c rdamedia Online-Ressource cr rdacarrier Among comorbidities of obesity, hypothyroidism is the most common endocrinopathy. The pathogenesis of both diseases is based on serotonin deficiency. The article tells about a clinical case of a patient with obesity and subclinical hypothyroidism; a comprehensive examination allowed to choose the efficient and safe pathogenetic therapy. obesity hypothyroidism sibutramine mass spectrometry Medicine R M. O. Galieva verfasserin aut M. S. Mikhina verfasserin aut N. V. Mazurina verfasserin aut In Медицинский совет Remedium Group LLC, 2019 (2017), 3, Seite 80-83 (DE-627)1760607460 26585790 nnns year:2017 number:3 pages:80-83 https://doi.org/10.21518/2079-701X-2017-3-80-83 kostenfrei https://doaj.org/article/9e90ccae619242999620e890c01aa97f kostenfrei https://www.med-sovet.pro/jour/article/view/1755 kostenfrei https://doaj.org/toc/2079-701X Journal toc kostenfrei https://doaj.org/toc/2658-5790 Journal toc kostenfrei GBV_USEFLAG_A SYSFLAG_A GBV_DOAJ AR 2017 3 80-83 |
| language |
Russian |
| source |
In Медицинский совет (2017), 3, Seite 80-83 year:2017 number:3 pages:80-83 |
| sourceStr |
In Медицинский совет (2017), 3, Seite 80-83 year:2017 number:3 pages:80-83 |
| format_phy_str_mv |
Article |
| institution |
findex.gbv.de |
| topic_facet |
obesity hypothyroidism sibutramine mass spectrometry Medicine R |
| isfreeaccess_bool |
true |
| container_title |
Медицинский совет |
| authorswithroles_txt_mv |
E. A. Troshina @@aut@@ M. O. Galieva @@aut@@ M. S. Mikhina @@aut@@ N. V. Mazurina @@aut@@ |
| publishDateDaySort_date |
2017-01-01T00:00:00Z |
| hierarchy_top_id |
1760607460 |
| id |
DOAJ033461155 |
| language_de |
russisch |
| fullrecord |
<?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>01000caa a22002652 4500</leader><controlfield tag="001">DOAJ033461155</controlfield><controlfield tag="003">DE-627</controlfield><controlfield tag="005">20230505014249.0</controlfield><controlfield tag="007">cr uuu---uuuuu</controlfield><controlfield tag="008">230226s2017 xx |||||o 00| ||rus c</controlfield><datafield tag="024" ind1="7" ind2=" "><subfield code="a">10.21518/2079-701X-2017-3-80-83</subfield><subfield code="2">doi</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-627)DOAJ033461155</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-599)DOAJ9e90ccae619242999620e890c01aa97f</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-627</subfield><subfield code="b">ger</subfield><subfield code="c">DE-627</subfield><subfield code="e">rakwb</subfield></datafield><datafield tag="041" ind1=" " ind2=" "><subfield code="a">rus</subfield></datafield><datafield tag="100" ind1="0" ind2=" "><subfield code="a">E. A. Troshina</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">CLINICAL FOLLOW-UP OF A PATIENT WITH OBESITY AND SUBCLINICAL HYPOTHYROIDISM DURING TREATMENT WITH SIBUTRAMINE AND LEVOTHYROXINE SODIUM</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="c">2017</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="a">Text</subfield><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="a">Computermedien</subfield><subfield code="b">c</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="a">Online-Ressource</subfield><subfield code="b">cr</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="520" ind1=" " ind2=" "><subfield code="a">Among comorbidities of obesity, hypothyroidism is the most common endocrinopathy. The pathogenesis of both diseases is based on serotonin deficiency. The article tells about a clinical case of a patient with obesity and subclinical hypothyroidism; a comprehensive examination allowed to choose the efficient and safe pathogenetic therapy.</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">obesity</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">hypothyroidism</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">sibutramine</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">mass spectrometry</subfield></datafield><datafield tag="653" ind1=" " ind2="0"><subfield code="a">Medicine</subfield></datafield><datafield tag="653" ind1=" " ind2="0"><subfield code="a">R</subfield></datafield><datafield tag="700" ind1="0" ind2=" "><subfield code="a">M. O. Galieva</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="0" ind2=" "><subfield code="a">M. S. Mikhina</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="0" ind2=" "><subfield code="a">N. V. Mazurina</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="773" ind1="0" ind2="8"><subfield code="i">In</subfield><subfield code="t">Медицинский совет</subfield><subfield code="d">Remedium Group LLC, 2019</subfield><subfield code="g">(2017), 3, Seite 80-83</subfield><subfield code="w">(DE-627)1760607460</subfield><subfield code="x">26585790</subfield><subfield code="7">nnns</subfield></datafield><datafield tag="773" ind1="1" ind2="8"><subfield code="g">year:2017</subfield><subfield code="g">number:3</subfield><subfield code="g">pages:80-83</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">https://doi.org/10.21518/2079-701X-2017-3-80-83</subfield><subfield code="z">kostenfrei</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">https://doaj.org/article/9e90ccae619242999620e890c01aa97f</subfield><subfield code="z">kostenfrei</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">https://www.med-sovet.pro/jour/article/view/1755</subfield><subfield code="z">kostenfrei</subfield></datafield><datafield tag="856" ind1="4" ind2="2"><subfield code="u">https://doaj.org/toc/2079-701X</subfield><subfield code="y">Journal toc</subfield><subfield code="z">kostenfrei</subfield></datafield><datafield tag="856" ind1="4" ind2="2"><subfield code="u">https://doaj.org/toc/2658-5790</subfield><subfield code="y">Journal toc</subfield><subfield code="z">kostenfrei</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_USEFLAG_A</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SYSFLAG_A</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_DOAJ</subfield></datafield><datafield tag="951" ind1=" " ind2=" "><subfield code="a">AR</subfield></datafield><datafield tag="952" ind1=" " ind2=" "><subfield code="j">2017</subfield><subfield code="e">3</subfield><subfield code="h">80-83</subfield></datafield></record></collection>
|
| author |
E. A. Troshina |
| spellingShingle |
E. A. Troshina misc obesity misc hypothyroidism misc sibutramine misc mass spectrometry misc Medicine misc R CLINICAL FOLLOW-UP OF A PATIENT WITH OBESITY AND SUBCLINICAL HYPOTHYROIDISM DURING TREATMENT WITH SIBUTRAMINE AND LEVOTHYROXINE SODIUM |
| authorStr |
E. A. Troshina |
| ppnlink_with_tag_str_mv |
@@773@@(DE-627)1760607460 |
| format |
electronic Article |
| delete_txt_mv |
keep |
| author_role |
aut aut aut aut |
| collection |
DOAJ |
| remote_str |
true |
| illustrated |
Not Illustrated |
| issn |
26585790 |
| topic_title |
CLINICAL FOLLOW-UP OF A PATIENT WITH OBESITY AND SUBCLINICAL HYPOTHYROIDISM DURING TREATMENT WITH SIBUTRAMINE AND LEVOTHYROXINE SODIUM obesity hypothyroidism sibutramine mass spectrometry |
| topic |
misc obesity misc hypothyroidism misc sibutramine misc mass spectrometry misc Medicine misc R |
| topic_unstemmed |
misc obesity misc hypothyroidism misc sibutramine misc mass spectrometry misc Medicine misc R |
| topic_browse |
misc obesity misc hypothyroidism misc sibutramine misc mass spectrometry misc Medicine misc R |
| format_facet |
Elektronische Aufsätze Aufsätze Elektronische Ressource |
| format_main_str_mv |
Text Zeitschrift/Artikel |
| carriertype_str_mv |
cr |
| hierarchy_parent_title |
Медицинский совет |
| hierarchy_parent_id |
1760607460 |
| hierarchy_top_title |
Медицинский совет |
| isfreeaccess_txt |
true |
| familylinks_str_mv |
(DE-627)1760607460 |
| title |
CLINICAL FOLLOW-UP OF A PATIENT WITH OBESITY AND SUBCLINICAL HYPOTHYROIDISM DURING TREATMENT WITH SIBUTRAMINE AND LEVOTHYROXINE SODIUM |
| ctrlnum |
(DE-627)DOAJ033461155 (DE-599)DOAJ9e90ccae619242999620e890c01aa97f |
| title_full |
CLINICAL FOLLOW-UP OF A PATIENT WITH OBESITY AND SUBCLINICAL HYPOTHYROIDISM DURING TREATMENT WITH SIBUTRAMINE AND LEVOTHYROXINE SODIUM |
| author_sort |
E. A. Troshina |
| journal |
Медицинский совет |
| journalStr |
Медицинский совет |
| lang_code |
rus |
| isOA_bool |
true |
| recordtype |
marc |
| publishDateSort |
2017 |
| contenttype_str_mv |
txt |
| container_start_page |
80 |
| author_browse |
E. A. Troshina M. O. Galieva M. S. Mikhina N. V. Mazurina |
| format_se |
Elektronische Aufsätze |
| author-letter |
E. A. Troshina |
| doi_str_mv |
10.21518/2079-701X-2017-3-80-83 |
| author2-role |
verfasserin |
| title_sort |
clinical follow-up of a patient with obesity and subclinical hypothyroidism during treatment with sibutramine and levothyroxine sodium |
| title_auth |
CLINICAL FOLLOW-UP OF A PATIENT WITH OBESITY AND SUBCLINICAL HYPOTHYROIDISM DURING TREATMENT WITH SIBUTRAMINE AND LEVOTHYROXINE SODIUM |
| abstract |
Among comorbidities of obesity, hypothyroidism is the most common endocrinopathy. The pathogenesis of both diseases is based on serotonin deficiency. The article tells about a clinical case of a patient with obesity and subclinical hypothyroidism; a comprehensive examination allowed to choose the efficient and safe pathogenetic therapy. |
| abstractGer |
Among comorbidities of obesity, hypothyroidism is the most common endocrinopathy. The pathogenesis of both diseases is based on serotonin deficiency. The article tells about a clinical case of a patient with obesity and subclinical hypothyroidism; a comprehensive examination allowed to choose the efficient and safe pathogenetic therapy. |
| abstract_unstemmed |
Among comorbidities of obesity, hypothyroidism is the most common endocrinopathy. The pathogenesis of both diseases is based on serotonin deficiency. The article tells about a clinical case of a patient with obesity and subclinical hypothyroidism; a comprehensive examination allowed to choose the efficient and safe pathogenetic therapy. |
| collection_details |
GBV_USEFLAG_A SYSFLAG_A GBV_DOAJ |
| container_issue |
3 |
| title_short |
CLINICAL FOLLOW-UP OF A PATIENT WITH OBESITY AND SUBCLINICAL HYPOTHYROIDISM DURING TREATMENT WITH SIBUTRAMINE AND LEVOTHYROXINE SODIUM |
| url |
https://doi.org/10.21518/2079-701X-2017-3-80-83 https://doaj.org/article/9e90ccae619242999620e890c01aa97f https://www.med-sovet.pro/jour/article/view/1755 https://doaj.org/toc/2079-701X https://doaj.org/toc/2658-5790 |
| remote_bool |
true |
| author2 |
M. O. Galieva M. S. Mikhina N. V. Mazurina |
| author2Str |
M. O. Galieva M. S. Mikhina N. V. Mazurina |
| ppnlink |
1760607460 |
| mediatype_str_mv |
c |
| isOA_txt |
true |
| hochschulschrift_bool |
false |
| doi_str |
10.21518/2079-701X-2017-3-80-83 |
| up_date |
2024-07-03T17:52:48.998Z |
| _version_ |
1803581305913344000 |
| fullrecord_marcxml |
<?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>01000caa a22002652 4500</leader><controlfield tag="001">DOAJ033461155</controlfield><controlfield tag="003">DE-627</controlfield><controlfield tag="005">20230505014249.0</controlfield><controlfield tag="007">cr uuu---uuuuu</controlfield><controlfield tag="008">230226s2017 xx |||||o 00| ||rus c</controlfield><datafield tag="024" ind1="7" ind2=" "><subfield code="a">10.21518/2079-701X-2017-3-80-83</subfield><subfield code="2">doi</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-627)DOAJ033461155</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-599)DOAJ9e90ccae619242999620e890c01aa97f</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-627</subfield><subfield code="b">ger</subfield><subfield code="c">DE-627</subfield><subfield code="e">rakwb</subfield></datafield><datafield tag="041" ind1=" " ind2=" "><subfield code="a">rus</subfield></datafield><datafield tag="100" ind1="0" ind2=" "><subfield code="a">E. A. Troshina</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">CLINICAL FOLLOW-UP OF A PATIENT WITH OBESITY AND SUBCLINICAL HYPOTHYROIDISM DURING TREATMENT WITH SIBUTRAMINE AND LEVOTHYROXINE SODIUM</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="c">2017</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="a">Text</subfield><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="a">Computermedien</subfield><subfield code="b">c</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="a">Online-Ressource</subfield><subfield code="b">cr</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="520" ind1=" " ind2=" "><subfield code="a">Among comorbidities of obesity, hypothyroidism is the most common endocrinopathy. The pathogenesis of both diseases is based on serotonin deficiency. The article tells about a clinical case of a patient with obesity and subclinical hypothyroidism; a comprehensive examination allowed to choose the efficient and safe pathogenetic therapy.</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">obesity</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">hypothyroidism</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">sibutramine</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">mass spectrometry</subfield></datafield><datafield tag="653" ind1=" " ind2="0"><subfield code="a">Medicine</subfield></datafield><datafield tag="653" ind1=" " ind2="0"><subfield code="a">R</subfield></datafield><datafield tag="700" ind1="0" ind2=" "><subfield code="a">M. O. Galieva</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="0" ind2=" "><subfield code="a">M. S. Mikhina</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="0" ind2=" "><subfield code="a">N. V. Mazurina</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="773" ind1="0" ind2="8"><subfield code="i">In</subfield><subfield code="t">Медицинский совет</subfield><subfield code="d">Remedium Group LLC, 2019</subfield><subfield code="g">(2017), 3, Seite 80-83</subfield><subfield code="w">(DE-627)1760607460</subfield><subfield code="x">26585790</subfield><subfield code="7">nnns</subfield></datafield><datafield tag="773" ind1="1" ind2="8"><subfield code="g">year:2017</subfield><subfield code="g">number:3</subfield><subfield code="g">pages:80-83</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">https://doi.org/10.21518/2079-701X-2017-3-80-83</subfield><subfield code="z">kostenfrei</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">https://doaj.org/article/9e90ccae619242999620e890c01aa97f</subfield><subfield code="z">kostenfrei</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">https://www.med-sovet.pro/jour/article/view/1755</subfield><subfield code="z">kostenfrei</subfield></datafield><datafield tag="856" ind1="4" ind2="2"><subfield code="u">https://doaj.org/toc/2079-701X</subfield><subfield code="y">Journal toc</subfield><subfield code="z">kostenfrei</subfield></datafield><datafield tag="856" ind1="4" ind2="2"><subfield code="u">https://doaj.org/toc/2658-5790</subfield><subfield code="y">Journal toc</subfield><subfield code="z">kostenfrei</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_USEFLAG_A</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SYSFLAG_A</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_DOAJ</subfield></datafield><datafield tag="951" ind1=" " ind2=" "><subfield code="a">AR</subfield></datafield><datafield tag="952" ind1=" " ind2=" "><subfield code="j">2017</subfield><subfield code="e">3</subfield><subfield code="h">80-83</subfield></datafield></record></collection>
|
| score |
7.399296 |